Viewing Study NCT01738451


Ignite Creation Date: 2025-12-24 @ 11:43 PM
Ignite Modification Date: 2026-02-20 @ 1:45 PM
Study NCT ID: NCT01738451
Status: COMPLETED
Last Update Posted: 2017-11-13
First Post: 2012-11-15
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Evaluate the Effect of Repeat Oral Dosing of GSK2118436 on Cardiac Repolarization in Subjects With V600 BRAF Mutation-Positive Tumors
Sponsor: GlaxoSmithKline
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None ECG intervals and morphology View
None BRAF-mutation positive tumor View
None Holter monitor View
None BRAF inhibitor View
None GSK2118436 View
None safety View
None cancer View
None QTc View
None pharmacokinetics View